| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30012527 | HIV | ENSG00000090339.9 | protein_coding | ICAM1 | No | No | 3383 | P05362 |
| TVIS30012528 | HIV | ENSG00000090339.9 | protein_coding | ICAM1 | No | No | 3383 | P05362 |
| TVIS44007915 | HTLV-1 | ENSG00000090339.9 | protein_coding | ICAM1 | No | No | 3383 | P05362 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | ICAM1 |
|---|---|
| DrugBank ID | DB12598 |
| Drug Name | Nafamostat |
| Target ID | BE0001085 |
| UniProt ID | P05362 |
| Regulation Type | inhibitor |
| PubMed IDs | 25954127 |
| Citations | Kang MW, Song HJ, Kang SK, Kim Y, Jung SB, Jee S, Moon JY, Suh KS, Lee SD, Jeon BH, Kim CS: Nafamostat Mesilate Inhibits TNF-alpha-Induced Vascular Endothelial Cell Dysfunction by Inhibiting Reactive Oxygen Species Production. Korean J Physiol Pharmacol. 2015 May;19(3):229-34. doi: 10.4196/kjpp.2015.19.3.229. Epub 2015 Apr 30. |
| Groups | Investigational |
| Direct Classification | Guanidinobenzoic acids and derivatives |
| SMILES | NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC2=C(C=C1)C=C(C=C2)C(N)=N |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL273264 |
